2021 presentations

Melanoma: Keeping Up With the Data

Sarcoma: Where are We Making Progress?

Medical Therapy for Head and Neck Cancers: Current Status

Bladder Cancer: Sequencing Therapeutic Choices

RCC: A Surfeit of Riches – What’s a Clinician to Do?

Impact of COVID-19 on Cancer Care

Immunotherapy for Advanced NSCLC.

Matching Drugs to Targets in NSCLC

Therapeutic Advances in SCLC;

New Directions in the Treatment of ER+ Breast Cancer

Updates in the Treatment of HER2+ Breast Cancer

Triple Negative Breast Cancer: Immunotherapy and Novel Agents

Managing the Toxicity of Endocrine Therapy: Diet, Exercise, Sexual Health

Genomics to Guide Therapy in Early and Late Stage Breast Cancer

Metastatic Survivorship Care

SITC on Practical Recommendations Including Reimbursement Issues

Ovarian Cancer: PARP, Bevacizumab, Immunotherapy

Cervical and Uterine Cancer Updates